Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Schiller
KOREA E & EX

New Technology Could Revolutionize Treatment of Sepsis

By HospiMedica International staff writers
Posted on 16 Jul 2014
Image: The microchannel blood processor for preventing sepsis (Photo courtesy of OSU - Oregon State University).
Image: The microchannel blood processor for preventing sepsis (Photo courtesy of OSU - Oregon State University).
A small microchannel device for processing blood could be used to remove problematic endotoxins, helping to prevent sepsis.

Under development by researchers at Oregon State University (OSU; Corvallis, USA), the prototype device is a processor, about the size of a coffee mug, constructed of thousands of microchannels the width of a human hair that provide accelerated heat and mass transfer as fluids move through them. The microchannels are coated with what the researchers called “pendant polymer brushes,” repeating chains of carbon and oxygen atoms anchored to microchannel inner surface that help prevent blood proteins and cells from adhering or coagulating.

On the end of each such pendant chain is a bioactive peptide that binds tightly to the endotoxin and removes it from the blood, which is returned directly back to the patient. The microchannels can be produced in mass quantity and at low cost, stamped onto a range of metals or low-cost polymers, and can used to process a large volume of liquid in a comparatively short time. The low cost would also allow prophylactic treatment anytime there is a concern about sepsis developing, due to an injury, a wound, an operation, or an infection, and before sepsis becomes an issue.

“A big part of the problem with sepsis is that it moves so rapidly; by the time it’s apparent what the problem is, it’s often too late to treat it,” said Prof. Joe McGuire, PhD, head of the OSU department of chemical, biological, and environmental engineering. “If given early enough, antibiotics and other treatments can sometimes, but not always, stop this process. Once these bacterial fragments are in the blood stream the antibiotics won’t always work. You can have successfully eradicated the living bacteria even as you’re dying.”

Sepsis is characterized by a whole-body inflammatory state caused by the immune system's response to a serious infection, most commonly bacteria, but also fungi, viruses, and parasites in the blood, urinary tract, lungs, skin, or other tissues. Common symptoms of sepsis include those related to a specific infection, but usually accompanied by high fevers, hot, flushed skin, elevated heart rate, hyperventilation, altered mental status, swelling, and low blood pressure. Sepsis causes millions of deaths globally each year.

Related Links:

Oregon State University



Harloff
JD Honigberg International
Inditherm
RG Advertising

Channels

Surgical Techniques

view channel

Epidural Steroid Injections Could Help Avoid Surgery

For patients with lower back pain, epidural steroid injections (ESI) could reduce the need for surgery, according to a new study. Researchers at Massachusetts General Hospital (Boston, USA) conducted a systematic review and meta-analysis of studies to determine whether ESI could have a surgery-sparing effect in patients... Read more

Women's Health

view channel

Pregnant Women in Austria Experience Iodine Deficiency

A new study suggests that pregnant women in Austria have a potentially clinically significant iodine deficiency which could impair embryonic brain development. Researchers at the Medical University of Vienna (Austria) conducted a cross-sectional investigation of urinary iodine excretion in 246 pregnant women (2 in the... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more

Business

view channel

Abbott Completes Topera Acquisition

Abbott (Abbott Park, IL, USA) has completed its acquisition of Topera (Menlo Park, CA, USA), developer of innovative electrophysiology technologies for the diagnosis and treatment of atrial fibrillation (AF). The Topera rotor identification system helps physicians identify and target patient-specific rotors that have... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.